|
| Home : Hansa Biopharma: New Imlifidase Data Presented at ESOT, Copenhagen |
|
Aug 30
2019 |
Hansa Biopharma: New Imlifidase Data Presented at ESOT, Copenhagen |
|
LUND, Sweden, Aug. 30, 2019 /PRNewswire/ -- Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG-mediated diseases, announced today that new imlifidase data will be highlighted in a presentation at the 19th Congress of the European Society for Organ... |
|
|
|
| Source:https://www.prnewswire.com:443/news-releases/hansa-biopharma-new-imlifidase-data-presented-at-esot-copenhagen-300909608.html |
| |
|
Related News
|
» SKF Makes Group Management Appointment
» WntResearch Increases Resources for Out-licensing of Foxy-5
|
|
|
